美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=NDA204026"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
59572-503-00 59572-503 HUMAN PRESCRIPTION DRUG Pomalyst pomalidomide CAPSULE ORAL 20130218 N/A NDA NDA204026 Celgene Corporation POMALIDOMIDE 3 mg/1 100 CAPSULE in 1 BOTTLE (59572-503-00)
59572-503-21 59572-503 HUMAN PRESCRIPTION DRUG Pomalyst pomalidomide CAPSULE ORAL 20130218 N/A NDA NDA204026 Celgene Corporation POMALIDOMIDE 3 mg/1 21 CAPSULE in 1 BOTTLE (59572-503-21)
59572-502-00 59572-502 HUMAN PRESCRIPTION DRUG Pomalyst pomalidomide CAPSULE ORAL 20130218 N/A NDA NDA204026 Celgene Corporation POMALIDOMIDE 2 mg/1 100 CAPSULE in 1 BOTTLE (59572-502-00)
59572-502-21 59572-502 HUMAN PRESCRIPTION DRUG Pomalyst pomalidomide CAPSULE ORAL 20130218 N/A NDA NDA204026 Celgene Corporation POMALIDOMIDE 2 mg/1 21 CAPSULE in 1 BOTTLE (59572-502-21)
59572-501-00 59572-501 HUMAN PRESCRIPTION DRUG Pomalyst pomalidomide CAPSULE ORAL 20130218 N/A NDA NDA204026 Celgene Corporation POMALIDOMIDE 1 mg/1 100 CAPSULE in 1 BOTTLE (59572-501-00)
59572-501-21 59572-501 HUMAN PRESCRIPTION DRUG Pomalyst pomalidomide CAPSULE ORAL 20130218 N/A NDA NDA204026 Celgene Corporation POMALIDOMIDE 1 mg/1 21 CAPSULE in 1 BOTTLE (59572-501-21)
59572-504-00 59572-504 HUMAN PRESCRIPTION DRUG Pomalyst pomalidomide CAPSULE ORAL 20130218 N/A NDA NDA204026 Celgene Corporation POMALIDOMIDE 4 mg/1 100 CAPSULE in 1 BOTTLE (59572-504-00)
59572-504-21 59572-504 HUMAN PRESCRIPTION DRUG Pomalyst pomalidomide CAPSULE ORAL 20130218 N/A NDA NDA204026 Celgene Corporation POMALIDOMIDE 4 mg/1 21 CAPSULE in 1 BOTTLE (59572-504-21)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2025 Drugfuture->U.S. FDA National Drug Code DataBase